GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

GLP-1 receptor agonists like semaglutide and the dual GIP/GLP-1 agonist tirzepatide mimic naturally occurring hormones that regulate blood sugar, appetite, and digestion. GLP-1 (glucagon-like ...

More than 1 in 4 adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, the ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

In 2025, Släcka introduces a functional beverage designed to combat mid-afternoon cravings by offering a healthier ...

Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...

More evidence shows a risk between GLP-1 drugs and vision risks. A study in JAMA Network Open adds more evidence linking ...

Lexaria Bioscience Corp (NASDAQ:LEXX) stock climbed 3.4% following the announcement that the company has achieved a key ...

The company is also focused on strategic capital deployment. It has already invested in GLP-1 drug substance and drug product ...

More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 protein last year, ...